Abstract
An increased interest in surgical treatment of liver metastases from colorectal origin has evolved recently. However not all patients benefit from this approach, with early recurrence and death still being encountered. To evaluate clinical as well as perioperative factors that might significantly affect the outcome of patients with completely resected colorectal liver metastases, we examined 116 patients who underwent resection between September 1987 and August 1989. Median follow-up time was 13.2 months (0.6 to 31.4 months). The overall survival rate was 91% at 1 year and 75% at 2 years. Median survival was not reached. Median disease-free survival time was 11.5 months, with 49.4% and 21.2% of the patients being free of disease at 1 and 2 years, respectively. By univariate analysis, site of primary colorectal cancer, preoperative carcinoembryonic antigen (CEA) level, size of metastases, number of metastases, length of operation time, percentage mean arterial pressure, number of hypotensive episodes, duration of hypotensive episodes, and whole blood transfusion significantly affected recurrence rate following resection. However only site of primary tumor, CEA, number of metastases, and number of hypotensive episodes remained significant in the multivariate analysis. The most significant single factor that affected recurrence rate was the number of hypotensive episodes during the operative procedure. It is concluded that hypotensive episodes, even when well controlled, should be avoided during operation to maximize the chances of cure and prolong disease-free survival of patients with colorectal liver metastases.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abraham E., Chang Y. H. Effects of hemorrhage on inflammatory response. Arch Surg. 1984 Oct;119(10):1154–1157. doi: 10.1001/archsurg.1984.01390220040009. [DOI] [PubMed] [Google Scholar]
- Abraham E., Lee R. J., Chang Y. H. The role of interleukin 2 in hemorrhage-induced abnormalities of lymphocyte proliferation. Circ Shock. 1986;18(3):205–213. [PubMed] [Google Scholar]
- Adson M. A., Van Heerden J. A. Major hepatic resections for metastatic colorectal cancer. Ann Surg. 1980 May;191(5):576–583. doi: 10.1097/00000658-198005000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Attiyeh F. F., Wanebo H. J., Stearns M. W. Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum. 1978 Apr;21(3):160–162. doi: 10.1007/BF02586558. [DOI] [PubMed] [Google Scholar]
- Bengmark S., Hafström L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969 Jan;23(1):198–202. doi: 10.1002/1097-0142(196901)23:1<198::aid-cncr2820230126>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Bradpiece H. A., Benjamin I. S., Halevy A., Blumgart L. H. Major hepatic resection for colorectal liver metastases. Br J Surg. 1987 Apr;74(4):324–326. doi: 10.1002/bjs.1800740434. [DOI] [PubMed] [Google Scholar]
- Butler J., Attiyeh F. F., Daly J. M. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet. 1986 Feb;162(2):109–113. [PubMed] [Google Scholar]
- Coppa G. F., Eng K., Ranson J. H., Gouge T. H., Localio S. A. Hepatic resection for metastatic colon and rectal cancer. An evaluation of preoperative and postoperative factors. Ann Surg. 1985 Aug;202(2):203–208. doi: 10.1097/00000658-198508000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ekberg H., Tranberg K. G., Andersson R., Lundstedt C., Hägerstrand I., Ranstam J., Bengmark S. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986 Sep;73(9):727–731. doi: 10.1002/bjs.1800730917. [DOI] [PubMed] [Google Scholar]
- Flanagan L., Jr, Foster J. H. Hepatic resection for metastatic cancer. Am J Surg. 1967 Apr;113(4):551–557. doi: 10.1016/0002-9610(67)90206-1. [DOI] [PubMed] [Google Scholar]
- Fortner J. G. Recurrence of colorectal cancer after hepatic resection. Am J Surg. 1988 Mar;155(3):378–382. doi: 10.1016/s0002-9610(88)80086-2. [DOI] [PubMed] [Google Scholar]
- Foster R. S., Jr, Costanza M. C., Foster J. C., Wanner M. C., Foster C. B. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer. 1985 Mar 15;55(6):1195–1201. doi: 10.1002/1097-0142(19850315)55:6<1195::aid-cncr2820550610>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- Francis D. M., Judson R. T. Blood transfusion and recurrence of cancer of the colon and rectum. Br J Surg. 1987 Jan;74(1):26–30. doi: 10.1002/bjs.1800740110. [DOI] [PubMed] [Google Scholar]
- Gennari L., Doci R., Bignami P., Bozzetti F. Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg. 1986 Jan;203(1):49–54. doi: 10.1097/00000658-198601000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hyman N. H., Foster R. S., Jr, DeMeules J. E., Costanza M. C. Blood transfusions and survival after lung cancer resection. Am J Surg. 1985 Apr;149(4):502–507. doi: 10.1016/s0002-9610(85)80047-7. [DOI] [PubMed] [Google Scholar]
- Johnson J. T., Taylor F. H., Thearle P. B. Blood transfusion and outcome in stage III head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 1987 Mar;113(3):307–310. doi: 10.1001/archotol.1987.01860030083014. [DOI] [PubMed] [Google Scholar]
- Jubert A. V., Lee E. T., Hersh E. M., McBride C. M. Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res. 1973 Dec;15(6):399–403. doi: 10.1016/0022-4804(73)90110-8. [DOI] [PubMed] [Google Scholar]
- Kemeny M. M., Sugarbaker P. H., Smith T. J., Edwards B. K., Shawker T., Vermess M., Jones A. E. A prospective analysis of laboratory tests and imaging studies to detect hepatic lesions. Ann Surg. 1982 Feb;195(2):163–167. doi: 10.1097/00000658-198202000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
- Morrow C. E., Grage T. B., Sutherland D. E., Najarian J. S. Hepatic resection for secondary neoplasms. Surgery. 1982 Oct;92(4):610–614. [PubMed] [Google Scholar]
- Nordlinger B., Quilichini M. A., Parc R., Hannoun L., Delva E., Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg. 1987 Mar;205(3):256–263. doi: 10.1097/00000658-198703000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ridge J. A., Daly J. M. Treatment of colorectal hepatic metastases. Surg Gynecol Obstet. 1985 Dec;161(6):597–607. [PubMed] [Google Scholar]
- Salvatierra O., Jr, Vincenti F., Amend W., Potter D., Iwaki Y., Opelz G., Terasaki P., Duca R., Cochrum K., Hanes D. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg. 1980;192(4):543–552. doi: 10.1097/00000658-198010000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stephan R. N., Kupper T. S., Geha A. S., Baue A. E., Chaudry I. H. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg. 1987 Jan;122(1):62–68. doi: 10.1001/archsurg.1987.01400130068010. [DOI] [PubMed] [Google Scholar]
- Stephenson K. R., Steinberg S. M., Hughes K. S., Vetto J. T., Sugarbaker P. H., Chang A. E. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg. 1988 Dec;208(6):679–687. doi: 10.1097/00000658-198812000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wagner J. S., Adson M. A., Van Heerden J. A., Adson M. H., Ilstrup D. M. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984 May;199(5):502–508. doi: 10.1097/00000658-198405000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waymack J. P., Gallon L., Barcelli U., Trocki O., Alexander J. W. Effect of blood transfusions on immune function. III. Alterations in macrophage arachidonic acid metabolism. Arch Surg. 1987 Jan;122(1):56–60. doi: 10.1001/archsurg.1987.01400130062009. [DOI] [PubMed] [Google Scholar]
- Younes R. N., Rogatko A., Vydelingum N. A., Brennan M. F. Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats. Surgery. 1991 Mar;109(3 Pt 1):307–312. [PubMed] [Google Scholar]